These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7938114)

  • 1. Levemopamil injection after cerebral oligemia reduces spatial memory deficits in rats.
    Heim C; Sieklucka M; Sontag KH
    Pharmacol Biochem Behav; 1994 Jul; 48(3):613-9. PubMed ID: 7938114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levemopamil reduces spatial learning deficit following transient occlusion of common carotid arteries in normotensive rats.
    Block F; Szabo L; Jaspers RM; Heim C; Sontag KH
    Acta Neurol Scand; 1993 Jul; 88(1):35-40. PubMed ID: 8372627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies.
    Heim C; Zhang J; Lan J; Sieklucka M; Kurz T; Riederer P; Gerlach M; Sontag KH
    Eur J Neurosci; 2000 Feb; 12(2):715-25. PubMed ID: 10712651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging.
    Elger B; Seega J; Raschack M
    Eur J Pharmacol; 1994 Mar; 254(1-2):65-71. PubMed ID: 8206118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of spontaneous alcohol drinking and physical withdrawal by levemopamil, a novel Ca2+ channel antagonist, in rats.
    Rezvani AH; Pucilowski O; Grady DR; Janowsky D; O'Brien RA
    Pharmacol Biochem Behav; 1993 Oct; 46(2):365-71. PubMed ID: 8265691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion- and T2-weighted imaging: evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamil.
    Seega J; Elger B
    Magn Reson Imaging; 1993; 11(3):401-9. PubMed ID: 8505874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
    Szabo L; Hofmann HP
    Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the 21-aminosteroid U-74389G on spatial orientation in rats after a cerebral oligemic episode and iron-induced oxidative stress.
    Heim C; Kolasiewicz W; Sontag KH
    J Neural Transm (Vienna); 2000; 107(1):95-104. PubMed ID: 10809407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy with dizocilpine and levemopamil does not reduce ischemic neuronal injury in rats.
    Sano T; Patel PM; Drummond JC; Cole DJ
    J Neurosurg Anesthesiol; 1993 Jul; 5(3):194-201. PubMed ID: 8400759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach.
    Block F; Schwarz M
    Neuroscience; 1998 Feb; 82(3):791-803. PubMed ID: 9483536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient reduction of cerebral blood flow leads to longlasting increase in GABA content in vulnerable structures and decreased susceptibility to bicuculline induced seizures.
    Sieklucka M; Heim C; Block F; Sontag KH
    J Neural Transm Gen Sect; 1992; 88(2):87-94. PubMed ID: 1632944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects.
    Szabo L
    Arzneimittelforschung; 1989 Mar; 39(3):309-14. PubMed ID: 2757656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat.
    Sarti C; Pantoni L; Bartolini L; Inzitari D
    Behav Brain Res; 2002 Oct; 136(1):13-20. PubMed ID: 12385786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive degeneration of dopamine system functions after transient cerebral oligemia in rats.
    Heim C; Arzberger T; Sontag T; Xiao A; Herbinger KH; Weindl A; Sontag KH
    Brain Res; 1999 Dec; 851(1-2):235-46. PubMed ID: 10642849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats.
    Okada M; Amamoto T; Tomonaga M; Kawachi A; Yazawa K; Mine K; Fujiwara M
    Neuroscience; 1996 Mar; 71(1):17-25. PubMed ID: 8834389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased susceptibility to seizures induced by bicuculline after transient bilateral clamping of the carotid arteries in rats.
    Sieklucka M; Bortolotto Z; Heim C; Block F; Sontag KH
    J Neural Transm Gen Sect; 1991; 83(1-2):127-37. PubMed ID: 1850283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats.
    Elger B; Seega J; Brendel R
    Stroke; 1994 Sep; 25(9):1836-41. PubMed ID: 8073466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of levemopamil to improve histological outcome following temporary occlusion of the middle cerebral artery in cats.
    Gomi S; Greenberg JH; Croul S; Reivich M
    J Neurol Sci; 1995 Jun; 130(2):128-33. PubMed ID: 8586975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral studies of the effects of moderate oligemic hypoxia caused by bilateral clamping of carotid arteries in mice. Impairment of spatial working memory.
    Jóźwiak L; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(4-5):279-89. PubMed ID: 10091712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.